📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death. (2024)

First Author: Mannion J

Attributed to: Molecular Mechanisms of Cell Death funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.immuni.2024.04.025

PubMed Identifier: 38788712

Publication URI: http://europepmc.org/abstract/MED/38788712

Type: Journal Article/Review

Volume: 57

Parent Publication: Immunity

Issue: 7

ISSN: 1074-7613